THYROID EYE DISEASE (TED)

This study aims to see if a shorter treatment course works as well as the standard one for thyroid eye disease. It will involve 40 patients who show a good early response to the medication. Researchers will compare outcomes between patients receiving 4 infusions versus the usual …

This early-stage study is testing a new gene therapy called VV-14305 for people with moderate to severe thyroid eye disease. The therapy is given as an injection near the eye. Researchers will check if it's safe and if it can reduce eye bulging and other symptoms compared to a sh…

This study aims to see if adding two common supplements—a cholesterol-lowering statin and vitamin D—to standard care can help calm the inflammation and reduce symptoms in people with active Thyroid Eye Disease. Researchers will compare four groups over 24 weeks: standard care alo…

This study is testing whether a new injection called MHB018A can safely reduce eye bulging and other symptoms in people with long-term, moderate-to-severe Thyroid Eye Disease. About 150 participants will receive either the real injection or a placebo dummy shot every four weeks f…

This study is the next step for people who were in earlier trials for Thyroid Eye Disease (TED). It aims to see if a long-term injection called MHB018A can safely reduce eye bulging and other symptoms. It is specifically for people who did not get enough benefit from the placebo …